⌘K
Loading ticker…
As of 2026-08-24, Corcept Therapeutics Inc. (CORT) has a 3-month relative strength percentile of 98 and a leadership percentile of 99 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 83. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.4%, relative volume 0.87×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
CORT is held by 33 ETFs as of May 2026. Top owner: SCHA at 0.14% weight, $31M notional. Top 3 carry $74M.
Held by 107 ETFs · $1.0B across latest filings · largest weight 4.79% (LFSC).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.14% | $31M | +0.06 pp |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.38% | $23M | +0.17 pp |
| VHTVanguard Health Care ETF | 0.10% | $20M | +0.05 pp |
| SCHMSchwab U.S. Mid-Cap ETF | 0.12% | $18M | +0.05 pp |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.02% |
| $11M |
| — |
| VIOGVanguard S&P Small-Cap 600 Growth ETF | 0.77% | $8M | +0.35 pp |
| FNDA | 0.07% | $6M | +0.04 pp |
| LFSC | 4.79% | $5M | +3.28 pp |
| PSCH | 3.47% | $5M | +1.48 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $4M | — |
Showing 10 of 33 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CORT Jan avg: 6.22% median: 13.56% win: 75% σ: 28.98% n: 4 2022-04-12 → 2026-07-31 | CORT Feb avg: -4.36% median: -9.18% win: 25% σ: 10.51% n: 4 2022-04-12 → 2026-07-31 | CORT Mar avg: 28.16% median: 10.05% win: 100% σ: 40.43% n: 4 2022-04-12 → 2026-07-31 | CORT Apr avg: -7.13% median: -7.42% win: 40% σ: 19.63% n: 5 2022-04-12 → 2026-07-31 | CORT May avg: 17.56% median: 7.90% win: 80% σ: 21.50% n: 5 2022-04-12 → 2026-07-31 | CORT Jun avg: 7.26% median: 7.69% win: 60% σ: 13.07% n: 5 2022-04-12 → 2026-07-31 | CORT Jul avg: 15.45% median: 19.02% win: 80% σ: 14.79% n: 5 2022-04-12 → 2026-07-31 | CORT Aug avg: 3.41% median: -2.46% win: 50% σ: 17.81% n: 4 2022-04-12 → 2026-07-31 (current) | CORT Sep avg: 8.21% median: 9.25% win: 50% σ: 21.20% n: 4 2022-04-12 → 2026-07-31 | CORT Oct avg: 2.21% median: 4.44% win: 75% σ: 9.86% n: 4 2022-04-12 → 2026-07-31 | CORT Nov avg: 1.24% median: -0.61% win: 50% σ: 14.10% n: 4 2022-04-12 → 2026-07-31 | CORT Dec avg: -15.24% median: -16.15% win: 25% σ: 34.30% n: 4 2022-04-12 → 2026-07-31 |